These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12100125)

  • 21. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
    Giralt SA; LeMaistre CF; Vriesendorp HM; Andersson BS; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I
    J Clin Oncol; 1994 Sep; 12(9):1923-30. PubMed ID: 8083714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation: a review of delayed complications.
    Deeg HJ; Storb R; Thomas ED
    Br J Haematol; 1984 Jun; 57(2):185-208. PubMed ID: 6329256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow transplantation: its biology and role as treatment for acute and chronic leukemias.
    Champlin R; Gale RP
    Ann N Y Acad Sci; 1987; 511():447-58. PubMed ID: 2830829
    [No Abstract]   [Full Text] [Related]  

  • 27. [Whole body irradiation in conditioning for bone marrow transplantation. Experiences with 35 cases of leukemia].
    Prosperini G; Santeusanio E; Di Bartolomeo P; Iacone A; Muzii G
    Radiol Med; 1985 Apr; 71(4):243-7. PubMed ID: 3901148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The early complications of bone marrow transplantation.
    Champlin RE; Gale RP
    Semin Hematol; 1984 Apr; 21(2):101-8. PubMed ID: 6377500
    [No Abstract]   [Full Text] [Related]  

  • 29. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid cancers after bone marrow transplantation.
    Curtis RE; Rowlings PA; Deeg HJ; Shriner DA; Socíe G; Travis LB; Horowitz MM; Witherspoon RP; Hoover RN; Sobocinski KA; Fraumeni JF; Boice JD
    N Engl J Med; 1997 Mar; 336(13):897-904. PubMed ID: 9070469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Whole body irradiation in the conditioning of bone marrow transplantation. Current indications and limiting factors].
    Ganem G; Cosset JM; Le Bourgeois JP
    Ann Med Interne (Paris); 1989; 140(5):387-92. PubMed ID: 2688510
    [No Abstract]   [Full Text] [Related]  

  • 33. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
    Robin M; Guardiola P; Dombret H; Baruchel A; Esperou H; Ribaud P; Devergie A; Gluckman E; Socié G
    Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lung complications of hematopoietic stem cell transplantation].
    Philit F; Cordonnier C; Michallet M; Cordier JF
    Rev Mal Respir; 1996 Nov; 13(5 Suppl):S71-84. PubMed ID: 9011914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre.
    Bruno B; Souillet G; Bertrand Y; Werck-Gallois MC; So Satta A; Bellon G
    Bone Marrow Transplant; 2004 Jul; 34(2):143-7. PubMed ID: 15170172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant.
    Markiewicz M; Giebel S; Wyleioł I; Tomaszewska R; Miszczyk L; Gawlicka G; Wojnar J; Holowiecki J
    Ann Transplant; 2006; 11(2):21-2; discussion 32-43. PubMed ID: 17494285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary malignancies after bone marrow transplantation in adults.
    Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
    J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late effects of allogeneic bone marrow transplantation in children.
    Bender-Götze C
    Pediatrician; 1991; 18(1):71-5. PubMed ID: 1983864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
    Socié G; Curtis RE; Deeg HJ; Sobocinski KA; Filipovich AH; Travis LB; Sullivan KM; Rowlings PA; Kingma DW; Banks PM; Travis WD; Witherspoon RP; Sanders J; Jaffe ES; Horowitz MM
    J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.